Home > Insider Trading > Filing (0001555280-18-000109)

Filing Details

Accession Number:: 0001555280-18-000109
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-01 17:07:52
Reporting Period:: 2018-02-27

Accepted Time:: 2018-03-01 17:07:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1555280	Zoetis Inc.	ZTS	Pharmaceutical Preparations (2834)	460696167

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1567825	Alejandro Bernal	C/O Zoetis Inc. 10 Sylvan Way Parsippany NJ 07054	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-02-27	15,709	$46.09	22,019	No	4	M	Direct
Common Stock	Disposition	2018-02-27	15,709	$83.01	6,310	No	4	S	Direct
Common Stock	Acquisiton	2018-02-27	4,066	$0.00	10,376	No	4	M	Direct
Common Stock	Disposition	2018-02-27	1,990	$81.67	8,386	No	4	F	Direct
Common Stock	Acquisiton	2018-02-27	5,936	$0.00	14,322	No	4	M	Direct
Common Stock	Disposition	2018-02-27	2,905	$81.67	11,417	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2018-02-27	15,709	$0.00	15,709	$0.00
Common Stock	Restricted Stock Unit	Disposition	2018-02-27	4,067	$0.00	4,067	$0.00
Common Stock	Performance Award Unit	Disposition	2018-02-27	5,937	$0.00	5,937	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
43,320	No	4	M	Direct
11,554	No	4	M	Direct
0	No	4	M	Direct

Footnotes

The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.
Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
15,709 options granted February 27, 2015 at an exercise price of $46.09 per option.
Each option vests on the third anniversary of the date of grant.
Each option expires on the tenth anniversary of the date of grant.
22,341 options granted February 19, 2016 at an exercise price of $41.83 per option; and 20,979 options granted February 14, 2017 at an exercise price of $55.02 per option.
Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 4,066.5688 RSUs vested on February 27, 2018; 6,064.6389 RSUs will vest on February 19, 2019; and 5,489.3659 RSUs will vest on February 14, 2020.
Performance award units having a three-year performance period covering 2015-2017 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 27, 2018 and were settled in shares of Zoetis common stock.